Literature DB >> 9830021

Functional conservation of the human homolog of the yeast pre-mRNA splicing factor Prp17p.

L A Lindsey1, M A Garcia-Blanco.   

Abstract

Splicing of pre-mRNAs involves two sequential transesterification reactions commonly referred to as the first and second steps. In Saccharomyces cerevisiae, four proteins, Prp16p, Prp17p, Prp18p, and Slu7p are exclusively required for the second step of splicing. The human homologs of Prp16p, Prp17p, and Prp18p have been identified, and the human proteins hPrp16 and hPrp18 have been shown to be required for the second step of splicing in vitro. Here we provide further evidence for the functional conservation of the second step factors between yeast and humans. Human hPrp17, which is 35% identical to the S. cerevisiae protein, is able to partially rescue the temperature-sensitive phenotype in a yeast strain where PRP17 has been knocked out, suggesting that the human and yeast proteins are functionally conserved. Overexpression of hPrp17 in the knockout yeast strain partially rescues the splicing defect seen in vitro and in vivo. In HeLa cells, hPrp17 is highly concentrated in the nuclear speckles, as is SC35 and many other splicing factors, thus providing further support that this protein also functions as a splicing factor in humans.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9830021     DOI: 10.1074/jbc.273.49.32771

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  PSF and p54nrb bind a conserved stem in U5 snRNA.

Authors:  Rui Peng; Billy T Dye; Ismael Pérez; Daron C Barnard; Amanda B Thompson; James G Patton
Journal:  RNA       Date:  2002-10       Impact factor: 4.942

2.  Reversible inhibition of the second step of splicing suggests a possible role of zinc in the second step of splicing.

Authors:  Noam Shomron; Hadar Malca; Ida Vig; Gil Ast
Journal:  Nucleic Acids Res       Date:  2002-10-01       Impact factor: 16.971

3.  The carboxy terminal WD domain of the pre-mRNA splicing factor Prp17p is critical for function.

Authors:  L A Lindsey-Boltz; G Chawla; N Srinivasan; U Vijayraghavan; M A Garcia-Blanco
Journal:  RNA       Date:  2000-09       Impact factor: 4.942

4.  Functional analyses of interacting factors involved in both pre-mRNA splicing and cell cycle progression in Saccharomyces cerevisiae.

Authors:  C S Russell; S Ben-Yehuda; I Dix; M Kupiec; J D Beggs
Journal:  RNA       Date:  2000-11       Impact factor: 4.942

5.  Genetic and physical interactions between factors involved in both cell cycle progression and pre-mRNA splicing in Saccharomyces cerevisiae.

Authors:  S Ben-Yehuda; I Dix; C S Russell; M McGarvey; J D Beggs; M Kupiec
Journal:  Genetics       Date:  2000-12       Impact factor: 4.562

6.  Crystal structure of the functional domain of the splicing factor Prp18.

Authors:  J Jiang; D S Horowitz; R M Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

7.  Human step II splicing factor hSlu7 functions in restructuring the spliceosome between the catalytic steps of splicing.

Authors:  K Chua; R Reed
Journal:  Genes Dev       Date:  1999-04-01       Impact factor: 11.361

8.  Evidence for a role of Sky1p-mediated phosphorylation in 3' splice site recognition involving both Prp8 and Prp17/Slu4.

Authors:  S F Dagher; X D Fu
Journal:  RNA       Date:  2001-09       Impact factor: 4.942

9.  Dependence of pre-mRNA introns on PRP17, a non-essential splicing factor: implications for efficient progression through cell cycle transitions.

Authors:  Geetanjali Chawla; Aparna K Sapra; Uttam Surana; Usha Vijayraghavan
Journal:  Nucleic Acids Res       Date:  2003-05-01       Impact factor: 16.971

10.  PRP-17 and the pre-mRNA splicing pathway are preferentially required for the proliferation versus meiotic development decision and germline sex determination in Caenorhabditis elegans.

Authors:  Jessica Amrozowicz Kerins; Momoyo Hanazawa; Maia Dorsett; Tim Schedl
Journal:  Dev Dyn       Date:  2010-05       Impact factor: 3.780

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.